csirt@kutim:~/threat-intel/cve/CVE-2023-37897

Katalog CVE

CVSS 8.8 · High EPSS 2,8%

Kerentanan Improper Neutralization of Special Elements in Output Used by a Downstream Component ('Injection') pada getgrav grav. Skor CVSS 3.1 8.8 (High) menurut NVD.

Deskripsi (NVD)

Grav is a file-based Web-platform built in PHP. Grav is subject to a server side template injection (SSTI) vulnerability. The fix for another SSTI vulnerability using `|map`, `|filter` and `|reduce` twigs implemented in the commit `71bbed1` introduces bypass of the denylist due to incorrect return value from `isDangerousFunction()`, which allows to execute the payload prepending double backslash (`\\`). The `isDangerousFunction()` check in version 1.7.42 and onwards retuns `false` value instead of `true` when the `\` symbol is found in the `$name`. This vulnerability can be exploited if the attacker has access to: 1. an Administrator account, or 2. a non-administrator, user account that has Admin panel access and Create/Update page permissions. A fix for this vulnerability has been introduced in commit `b4c6210` and is included in release version `1.7.42.2`. Users are advised to upgrade. There are no known workarounds for this vulnerability.

Rincian

Terbit di NVD
18 Juli 2023
Terakhir diubah
17 Juni 2026
Status NVD
Modified
CVSS 3.1
8.8 (High), sumber NVD
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-74: Improper Neutralization of Special Elements in Output Used by a Downstream Component ('Injection')
CWE-393: Return of Wrong Status Code
EPSS (30 hari)
2,8% peluang dieksploitasi; lebih tinggi dari 86,1% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
getgrav grav Versi 1.7.42
getgrav grav Versi 1.7.42.1

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.